Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.20 -0.13 (-3.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025)

Updated

Camp4 Therapeutics (CAMP) reported Other Accumulated Expenses of $27,000 for Q4 2025, down 84.7% from $176,000 a year earlier.

Analysis

Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025) Analysis & Trends

Dating back to Q4 2023, Camp4 Therapeutics' Other Accumulated Expenses record includes 4 quarters.

  • By year, Other Accumulated Expenses came in at $176,000 in FY2024 (-39.1%) and $289,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Camp4 Therapeutics 341.83 Mn -77.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 27,000.00
Dec 31, 2024 176,000.00
Sep 30, 2024 369,000.00
Dec 31, 2023 289,000.00
API Access

Camp4 Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CAMP&period=max&api_key=YOUR_API_KEY